QTTB

Q32 Bio Inc.

Q32 Bio Inc. (QTTB) has 3 SEC Form 4 filings (5 transaction rows) in the rolling window, disclosed by 2 distinct insiders. Most recent filing: Jul 2, 2026.

Insiders have net bought $30.0M over the trailing 6 months. The largest single insider purchase in this window was $15.0M by Director, 10% Owner Xu Diyong on May 28, 2026.

  • Industry:Biotechnology
  • CEO:Jodie Pope Morrison
  • Employees:22
  • HQ:Waltham, MA, US
  • IPO:2018-03-28

Insider Buying

$30.0M

reported purchases (SEC code P)

Insider Selling

$0

reported sales (SEC code S)

Unique Insiders

2

in the rolling window

Market Cap

$257.9M

latest known value

Source
Xu DiyongFirst filing
Purchase$15.0MJun 2SEC ↗
Purchase$15.0MJun 2SEC ↗

Related companies

Q32 Bio Inc. is in the Healthcare sector.